Notícias ImmunityBio Inc - IBRX | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
ImmunityBio Inc (IBRX)
ImmunityBio Inc (IBRX) Notícias

ImmunityBio Inc (IBRX)

2,62

-0,05

(-1,87%)

Fechado 22 Dezembro 6:00PM

Atrasado por 15 minutos

2,6499

0,0299

(1,14%)

Após o horário de negociação: 9:54PM

Atrasado por 15 minutos

Discussões em tempo real e ideias de negociação: Negocie com confiança com nossa poderosa plataforma.

D. Boral Capital Served as Co-Manager to ImmunityBio, Inc. (Nasdaq: IBRX) in connection with its $100.0 Million Underwritten Public Offering

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 8-K - Current report

ImmunityBio, Inc. Announces Pricing of Public Offering of Common Stock

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

ImmunityBio, Inc. Announces Proposed Public Offering of Common Stock

ImmunityBio and nCartes Enter Collaboration Agreement on Clinical Trial Data Fulfillment

ImmunityBio, Inc. Investor Alert (NASDAQ: IBRX): Schubert Jonckheer & Kolbe LLP Investigating Potential Shareholder Claims Against the Company's Officers and Directors for Possible False Statements

Form 8-K - Current report

ImmunityBio Completes ANKTIVA’s Post-Approval Enrollment of the 100th Patient in BCG Unresponsive NMIBC CIS Trial and Reports a Complete Response Rate of 71% with a Durable Duration of Response Ranging Up to 54 Months

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

ImmunityBio Reports Third-Quarter 2024 Financial Results

First Patients Dosed in Phase 1 Clinical Study of ImmunityBio’s CAR-NK Cell Therapy for the Treatment of Relapsed B-Cell Non-Hodgkin Lymphoma

ImmunityBio to Participate in the Jefferies London Healthcare Conference

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições